Ocrevus treatment leads to long-term changes in immune cell function in MS patients

The reprogramming of T-cells by Ocrevus highlights the potential for fine-tuning immune responses. This could revolutionize MS treatments and pave the way for broader autoimmune therapies.

[View original comment]

KillBait - News highlights delivered clearly and responsibly—no clickbait, no sensationalism.

KillBait is a news aggregator developed by students and professionals in journalism and web development. Our focus is on providing readers with clear and relevant summaries of each news story.